BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26926494)

  • 1. Nrf2 as molecular target for polyphenols: A novel therapeutic strategy in diabetic retinopathy.
    Nabavi SF; Barber AJ; Spagnuolo C; Russo GL; Daglia M; Nabavi SM; Sobarzo-Sánchez E
    Crit Rev Clin Lab Sci; 2016 Oct; 53(5):293-312. PubMed ID: 26926494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic regulation of redox signaling in diabetic retinopathy: Role of Nrf2.
    Kowluru RA; Mishra M
    Free Radic Biol Med; 2017 Feb; 103():155-164. PubMed ID: 28012783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nrf2: a potential therapeutic target for diabetic neuropathy.
    Kumar A; Mittal R
    Inflammopharmacology; 2017 Aug; 25(4):393-402. PubMed ID: 28353124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NRF2 plays a protective role in diabetic retinopathy in mice.
    Xu Z; Wei Y; Gong J; Cho H; Park JK; Sung ER; Huang H; Wu L; Eberhart C; Handa JT; Du Y; Kern TS; Thimmulappa R; Barber AJ; Biswal S; Duh EJ
    Diabetologia; 2014 Jan; 57(1):204-13. PubMed ID: 24186494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disorders.
    Kim J; Cha YN; Surh YJ
    Mutat Res; 2010 Aug; 690(1-2):12-23. PubMed ID: 19799917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the Nrf2 pathway against cardiovascular disease.
    Li J; Ichikawa T; Janicki JS; Cui T
    Expert Opin Ther Targets; 2009 Jul; 13(7):785-94. PubMed ID: 19530984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of NRF2 in Breast Cancer and Possible Therapeutical Role of Polyphenols and Melatonin.
    Tascioglu Aliyev A; Panieri E; Stepanić V; Gurer-Orhan H; Saso L
    Molecules; 2021 Mar; 26(7):. PubMed ID: 33805996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals.
    Surh YJ; Kundu JK; Na HK
    Planta Med; 2008 Oct; 74(13):1526-39. PubMed ID: 18937164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A potent Nrf2 activator, dh404, bolsters antioxidant capacity in glial cells and attenuates ischaemic retinopathy.
    Deliyanti D; Lee JY; Petratos S; Meyer CJ; Ward KW; Wilkinson-Berka JL; de Haan JB
    Clin Sci (Lond); 2016 Aug; 130(15):1375-87. PubMed ID: 27005782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the catecholic and the electrophilic moieties of caffeic acid in Nrf2/Keap1 pathway activation in ovarian carcinoma cell lines.
    Sirota R; Gibson D; Kohen R
    Redox Biol; 2015; 4():48-59. PubMed ID: 25498967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nrf2 as a chemoprevention target in gastrointestinal carcinoma].
    Gao P; Tang XW; Wang XJ
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Jul; 41(4):453-63. PubMed ID: 22927084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress targets in pulmonary emphysema: focus on the Nrf2 pathway.
    Boutten A; Goven D; Boczkowski J; Bonay M
    Expert Opin Ther Targets; 2010 Mar; 14(3):329-46. PubMed ID: 20148719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease.
    Ahuja M; Ammal Kaidery N; Yang L; Calingasan N; Smirnova N; Gaisin A; Gaisina IN; Gazaryan I; Hushpulian DM; Kaddour-Djebbar I; Bollag WB; Morgan JC; Ratan RR; Starkov AA; Beal MF; Thomas B
    J Neurosci; 2016 Jun; 36(23):6332-51. PubMed ID: 27277809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural dietary anti-cancer chemopreventive compounds: redox-mediated differential signaling mechanisms in cytoprotection of normal cells versus cytotoxicity in tumor cells.
    Nair S; Li W; Kong AN
    Acta Pharmacol Sin; 2007 Apr; 28(4):459-72. PubMed ID: 17376285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NRF2 targeting: a promising therapeutic strategy in chronic obstructive pulmonary disease.
    Boutten A; Goven D; Artaud-Macari E; Boczkowski J; Bonay M
    Trends Mol Med; 2011 Jul; 17(7):363-71. PubMed ID: 21459041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous Activation of Nrf2 and Elevation of Dietary and Endogenous Antioxidant Chemicals for Cancer Prevention in Humans.
    Prasad KN
    J Am Coll Nutr; 2016; 35(2):175-84. PubMed ID: 26151600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of molecular mechanisms involved in the activation of the Nrf2-ARE signaling pathway by chemopreventive agents.
    Giudice A; Arra C; Turco MC
    Methods Mol Biol; 2010; 647():37-74. PubMed ID: 20694660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear factor (erythroid-derived 2)-like 2 (NFE2L2) is a novel therapeutic target for diabetic complications.
    Xu X; Luo P; Wang Y; Cui Y; Miao L
    J Int Med Res; 2013 Feb; 41(1):13-9. PubMed ID: 23569125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical role of Nrf2 in oxidative stress-induced retinal ganglion cell death.
    Himori N; Yamamoto K; Maruyama K; Ryu M; Taguchi K; Yamamoto M; Nakazawa T
    J Neurochem; 2013 Dec; 127(5):669-80. PubMed ID: 23721546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-140-5p attenuated oxidative stress in Cisplatin induced acute kidney injury by activating Nrf2/ARE pathway through a Keap1-independent mechanism.
    Liao W; Fu Z; Zou Y; Wen D; Ma H; Zhou F; Chen Y; Zhang M; Zhang W
    Exp Cell Res; 2017 Nov; 360(2):292-302. PubMed ID: 28928081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.